Literature DB >> 10800747

Morphological changes in neuropeptide Y-positive fiber in the hippocampal formation of schizophrenics.

S Iritani1, N Kuroki, K Niizato, K Ikeda.   

Abstract

1. The authors observed NPY-positive fibers in the CA4 area of the hippocampus from schizophrenics and normal controls using immunohistochemical techniques. 2. Positive fibers followed a straight course and were oriented to exit the CA4 region of hippocampus in normal controls. 3. Many NPY-positive fibers in the CA4 area appeared coiled or helix-like or appeared wasted and thread-like in schizophrenic brains, compared to those of normal controls. 4. These findings may indicate a dysfunction of the interneuron in the schizophrenic brain and support the hypothesis of developmental impairments of the CNS in schizophrenia, and these morphological changes in fibers may relate to schizophrenic symptoms such as memory or/and learning deterioration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10800747     DOI: 10.1016/s0278-5846(99)00102-5

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  6 in total

Review 1.  Neurodevelopment, GABA system dysfunction, and schizophrenia.

Authors:  Martin J Schmidt; Karoly Mirnics
Journal:  Neuropsychopharmacology       Date:  2014-04-24       Impact factor: 7.853

2.  Neuropeptides involved in the pathophysiology of schizophrenia and major depression.

Authors:  David De Wied; Hein O. Sigling
Journal:  Neurotox Res       Date:  2002 Aug-Sep       Impact factor: 3.911

Review 3.  Studies on the hippocampal formation: From basic development to clinical applications: Studies on schizophrenia.

Authors:  Robert Freedman; Dan Goldowitz
Journal:  Prog Neurobiol       Date:  2009-10-21       Impact factor: 11.685

4.  Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways.

Authors:  C Anthony Altar; Pascal Laeng; Linda W Jurata; Jeffrey A Brockman; Andrew Lemire; Jeffrey Bullard; Yury V Bukhman; Theresa A Young; Vinod Charles; Michael G Palfreyman
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

5.  Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.

Authors:  Gursharan Chana; Chad A Bousman; Tammie T Money; Andrew Gibbons; Piers Gillett; Brian Dean; Ian P Everall
Journal:  Front Cell Neurosci       Date:  2013-06-26       Impact factor: 5.505

Review 6.  What happens in the brain of schizophrenia patients?: an investigation from the viewpoint of neuropathology.

Authors:  Shuji Iritani
Journal:  Nagoya J Med Sci       Date:  2013-02       Impact factor: 1.131

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.